These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17927270)

  • 1. Azole-bridged diplatinum anticancer compounds. Modulating DNA flexibility to escape repair mechanism and avoid cross resistance.
    Spiegel K; Magistrato A; Carloni P; Reedijk J; Klein ML
    J Phys Chem B; 2007 Oct; 111(41):11873-6. PubMed ID: 17927270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of novel azole-bridged dinuclear platinum(II) anticancer drugs to DNA: insights from hybrid QM/MM molecular dynamics simulations.
    Magistrato A; Ruggerone P; Spiegel K; Carloni P; Reedijk J
    J Phys Chem B; 2006 Mar; 110(8):3604-13. PubMed ID: 16494416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameterization of azole-bridged dinuclear platinum anticancer drugs via a QM/MM force matching procedure.
    Spiegel K; Magistrato A; Maurer P; Ruggerone P; Rothlisberger U; Carloni P; Reedijk J; Klein ML
    J Comput Chem; 2008 Jan; 29(1):38-49. PubMed ID: 17705162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin adducts on a GGG sequence within a DNA duplex studied by NMR spectroscopy and molecular dynamics simulations.
    Téletchéa S; Skauge T; Sletten E; Kozelka J
    Chemistry; 2009 Nov; 15(45):12320-37. PubMed ID: 19813235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pyrazolato-bridged dinuclear platinum(II) complex induces only minor distortions upon DNA-binding.
    Teletchéa S; Komeda S; Teuben JM; Elizondo-Riojas MA; Reedijk J; Kozelka J
    Chemistry; 2006 May; 12(14):3741-53. PubMed ID: 16514681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
    Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
    Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
    Zhou L
    J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA cross-linking patterns induced by an antitumor-active trinuclear platinum complex and comparison with its dinuclear analogue.
    Zhu J; Zhao Y; Zhu Y; Wu Z; Lin M; He W; Wang Y; Chen G; Dong L; Zhang J; Lu Y; Guo Z
    Chemistry; 2009; 15(21):5245-53. PubMed ID: 19350599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
    Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ
    Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex.
    Wu Y; Pradhan P; Havener J; Boysen G; Swenberg JA; Campbell SL; Chaney SG
    J Mol Biol; 2004 Aug; 341(5):1251-69. PubMed ID: 15321720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin.
    Scheeff ED; Briggs JM; Howell SB
    Mol Pharmacol; 1999 Sep; 56(3):633-43. PubMed ID: 10462551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
    Kasparkova J; Vojtiskova M; Natile G; Brabec V
    Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts.
    Beljanski V; Villanueva JM; Doetsch PW; Natile G; Marzilli LG
    J Am Chem Soc; 2005 Nov; 127(45):15833-42. PubMed ID: 16277526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,2-GG intrastrand cross-link of antitumor dinuclear bifunctional platinum compound with spermidine linker inhibits DNA polymerization more effectively than the cross-link of conventional cisplatin.
    Moriarity B; Nováková O; Farrell N; Brabec V; Kaspárková J
    Arch Biochem Biophys; 2007 Mar; 459(2):264-72. PubMed ID: 17224122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA conformation and repair of polymeric natural DNA damaged by antitumor azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Kasparkova J; Suchankova T; Komeda S; Brabec V
    J Inorg Biochem; 2012 Sep; 114():15-23. PubMed ID: 22687561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes.
    Ahmad S
    Chem Biodivers; 2010 Mar; 7(3):543-66. PubMed ID: 20232326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interaction of DNA with bisplatinum(II) complexes having bis(vicinal 1,2-diamines) as ligand.
    Büning H; Altman J; Beck W; Zorbas H
    Biochemistry; 1997 Sep; 36(38):11408-18. PubMed ID: 9298960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origins of the distortions in the base pair step adjacent to platinum anticancer drug-DNA adducts. Fundamental NMR solution studies utilizing right-handed cross-link models having 5'- and 3'-flanking residues.
    Saad JS; Natile G; Marzilli LG
    J Am Chem Soc; 2009 Sep; 131(34):12314-24. PubMed ID: 19655752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations.
    Spiegel K; Magistrato A
    Org Biomol Chem; 2006 Jul; 4(13):2507-17. PubMed ID: 16791311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.